Everything below concerns mass spectrometry. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
Reversed-phase high-performance liquid chromatography is the standard technique for estimating peptide purity. The result is a peak-area percentage, which describes how much of the detected material elutes as the main peak in one run. Mass spectrometry confirms the molecular mass and can reveal truncated, adducted, or otherwise modified species. Amino acid analysis or tandem mass spectrometry can address sequence fidelity when identity is in doubt. None of these measurements, taken alone, establishes that a sample is fit for any specific purpose.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
| Property | Value | Notes |
|---|---|---|
| Principal proposed target | GABA-A receptor complex | Hypothesis derived mainly from animal pharmacology |
| Common behavioral assay | Elevated plus maze | Rodent test for anxiety-like behavior |
| Reported molecular marker | Hippocampal BDNF expression | Measured by immunoassay or mRNA quantification |
| Typical dosing route | Intranasal | Chosen to reduce first-pass metabolism |
| Reported plasma half-life | Minutes | Based on limited peptide stability data |
Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.
Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.
Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.
Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.
They set out to determine whether or not the 13-minute isotope was indeed an isotope of protactinium. Between 1934 and 1938, Hahn, Meitner and Strassmann found a great number of radioactive transmutation products, all of which they regarded as transuranic. At that time, the existence of actinides was not yet established, and uranium was wrongly believed to be a group 6 element similar to tungsten. It followed that the first transuranic elements would be similar to group 7 to 10 elements, i.e. rhenium and platinoids. They established the presence of multiple isotopes of at least four such elements, and (mistakenly) identified them as elements with atomic numbers 93 through 96. They were the first scientists to measure the 23-minute half-life of uranium-239 and to establish chemically that it was an isotope of uranium, but were unable to continue this work to its logical conclusion and identify the real element 93. They identified ten different half-lives, with varying degrees of certainty. To account for them, Meitner had to hypothesise a new class of reaction and the alpha decay of uranium, neither of which had ever been reported before, and for which physical evidence was lacking. Hahn and Strassmann refined their chemical procedures, while Meitner devised new experiments to shine more light on the reaction processes.
To fill an iatrogenic defect or cavity caused by significant tissue loss due to injury, surgical excision or debridement, which would predispose the area to postoperative seroma and/or abscess formation; To close a gaping wound that cannot be sutured directly, have difficulty healing by secondary intention and the remaining tissue is unable to support a graft; To reduce tension across the wound, which would disrupt healing and lead to excessive scarring or wound dehiscence, or; To reconstruct complex anatomic structures like breasts or jaws, as flaps may also carry over tissues such as muscles and bones that may be useful in partially restoring functions within the body region.
Multi-substrate analogue inhibitors are high affinity selective inhibitors that can be prepared for enzymes that catalyse reactions with more than one substrate by capturing the binding energy of each of those substrate into one molecule. For example, in the formyl transfer reactions of purine biosynthesis, a potent Multi-substrate Adduct Inhibitor (MAI) to glycinamide ribonucleotide (GAR) TFase was prepared synthetically by linking analogues of the GAR substrate and the N-10-formyl tetrahydrofolate cofactor together to produce thioglycinamide ribonucleotide dideazafolate (TGDDF), or enzymatically from the natural GAR substrate to yield GDDF. Here the subnanomolar dissociation constant (KD) of TGDDF was greater than predicted presumably due to entropic advantages gained and/or positive interactions acquired through the atoms linking the components. MAIs have also been observed to be produced in cells by reactions of pro-drugs such as isoniazid or enzyme inhibitor ligands (for example, PTC124) with cellular cofactors such as nicotinamide adenine dinucleotide (NADH) and adenosine triphosphate (ATP) respectively.
In the 2021 Census of Population conducted by Statistics Canada, the census districts within the former city had a population of 629,941 living in 218,928 of its 228,939 total private dwellings, a change of −0.3% from its 2016 population of 632,098. With a land area of 187.70 square kilometres (72.47 sq mi), it had a population density of 3,356.1 people/km2 (8,692 people/sq mi) in 2021. The majority of the district's population is between 25 and 64 years old. 52% fell into that "working age" during the last major survey, which also found 21% of Scarborough's population was 14 years old or younger, 15% were between 15 and 24, while senior citizens aged 65+ made up the remaining 12%. Like the rest of Canada, the population is aging. It is projected that close to 30% of Scarborough residents will be senior citizens by 2041. Scarborough has a large number of retirement communities, which attracts more seniors to the area creating a situation where the two largest age demographics in Scarborough will be over 55 and under 25.
February 15: Law amending the decree of July 29, 1939, on family and French natality. March 29: Law creating a single wage allowance (ASU). April 2: Law on divorce and legal separation. September 2: Law on birth protection. September 14: Law concerning sentence adjustments. 1942
Sources: en.wikipedia.org
Ischemia (restriction of blood flow) leading to the death of muscle tissue, as in Volkmann's contracture. Muscle injury leading to adhesions and fibrosis (internal scarring). Fibrosis occurs within a muscle or organ, whereas adhesions bind two separate tissues or organs together. Immobilization, A muscle imbalance between an agonist and antagonist muscle, In response to impending muscle damage associated with ATP (energy) deficiency, Congenital abnormalities of muscle development.
==== Lithium ==== Lithium has been used to augment antidepressant therapy in those who have failed to respond to antidepressants alone. As an augmentation agent for major depression, lithium is much more effective than placebo. Lithium augmentation has proven efficacy in treating major depressive disorder in multiple randomized controlled trials. For treatment-resistant depression, lithium augmentation reduces the odds of remaining ill by 56-95%. In the STAR-D study, for patients who had not achieved remission with two previous treatment trials, an additional 15.9% achieved remission. A disadvantage of lithium versus other augmentation agents is the need for occasional blood tests to monitor lithium levels. Lithium dramatically decreases the suicide risk in recurrent major depression by 88.5%. In addition to its effects on suicide, lithium also decreases mortality from all causes in people with mood disorders.
== History == Turquoise was mined by pre-Columbian Native Americans in deposits in New Mexico (Los Cerrillos) and likely in California as well. Additionally, it was used by the Ancient Egyptians, although not very commonly. Several turquoise artefacts, such as beads and reclining calves, have also been found in Greece, dating to the Mycenaean era (1500BC). Turquoise mining later attracted brief European interest in the late 1800s. Prices peaked in 1890, then collapsed by 1912, ending large-scale operations. During Mohammad Khodabanda reign (1578–1587), accumulated turquoise dust from fifty years of mining in Safavid Iran was squandered lavishly, reflecting royal excess amid economic hardship, political discord, and rising factionalism among the qezelbash elite.
== Origin of eukaryotes == The great oxygenation event began with the biologically induced appearance of oxygen in the Earth's atmosphere about 2.45 billion years ago. The rise of oxygen levels due to cyanobacterial photosynthesis in ancient microenvironments was probably highly toxic to the surrounding biota. Under these conditions, the selective pressure of oxidative stress is thought to have driven the evolutionary transformation of an archaeal lineage into the first eukaryotes. Oxidative stress might have acted in synergy with other environmental stresses (such as ultraviolet radiation and/or desiccation) to drive this selection. Selective pressure for efficient repair of oxidative DNA damages may have promoted the evolution of eukaryotic sex involving such features as cell-cell fusions, cytoskeleton-mediated chromosome movements and emergence of the nuclear membrane. Thus, the evolution of meiotic sex and eukaryogenesis may have been inseparable processes that evolved in large part to facilitate repair of oxidative DNA damages.
Sources: en.wikipedia.org
Intranasal administration predominates in both animal and human research because it avoids hepatic first-pass metabolism. Injectable and intraperitoneal routes appear in animal work mainly for comparison.
Behavioral endpoints include time spent in open arms of the elevated plus maze and avoidance latencies. Biochemical endpoints include BDNF concentration, cytokine levels, and monoamine metabolite ratios in brain tissue.
Most published studies are small, originate from a limited number of laboratories, and lack independent replication. Dose-response relationships, measured brain exposure, and long-term outcomes are not well characterized.
Sealed, desiccated storage at -20 °C or colder is the standard recommendation for research-grade material. Vials should reach room temperature before they are opened, which limits condensation. Repeated temperature cycling is discouraged.